These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25748319)

  • 1. Cerebral autoregulation, beta amyloid, and white matter hyperintensities are interrelated.
    Brickman AM; Guzman VA; Gonzalez-Castellon M; Razlighi Q; Gu Y; Narkhede A; Janicki S; Ichise M; Stern Y; Manly JJ; Schupf N; Marshall RS
    Neurosci Lett; 2015 Apr; 592():54-8. PubMed ID: 25748319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer-Related Cerebrovascular Disease in Down Syndrome.
    Lao PJ; Gutierrez J; Keator D; Rizvi B; Banerjee A; Igwe KC; Laing KK; Sathishkumar M; Moni F; Andrews H; Krinsky-McHale S; Head E; Lee JH; Lai F; Yassa MA; Rosas HD; Silverman W; Lott IT; Schupf N; Brickman AM
    Ann Neurol; 2020 Dec; 88(6):1165-1177. PubMed ID: 32944999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
    Yew B; Nation DA;
    Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma soluble TREM2 is associated with white matter lesions independent of amyloid and tau.
    Tsai HH; Chen YF; Yen RF; Lo YL; Yang KC; Jeng JS; Tsai LK; Chang CF
    Brain; 2021 Dec; 144(11):3371-3380. PubMed ID: 34515756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are the brain's vascular and Alzheimer pathologies additive or interactive?
    Koncz R; Sachdev PS
    Curr Opin Psychiatry; 2018 Mar; 31(2):147-152. PubMed ID: 29232251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain amyloid burden and cerebrovascular disease are synergistically associated with neurometabolism in cognitively unimpaired older adults.
    Schreiner SJ; Kirchner T; Narkhede A; Wyss M; Van Bergen JMG; Steininger SC; Gietl A; Leh SE; Treyer V; Buck A; Pruessmann KP; Nitsch RM; Hock C; Henning A; Brickman AM; Unschuld PG
    Neurobiol Aging; 2018 Mar; 63():152-161. PubMed ID: 29310864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small vessel cerebrovascular disease is associated with cognition in prospective Alzheimer's clinical trial participants.
    Morales CD; Cotton-Samuel D; Lao PJ; Chang JF; Pyne JD; Alshikho MJ; Lippert RV; Bista K; Hale C; Edwards NC; Igwe KC; Deters K; Zimmerman ME; Brickman AM
    Alzheimers Res Ther; 2024 Feb; 16(1):25. PubMed ID: 38308344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain Amyloid PET Tracer Delivery is Related to White Matter Integrity in Patients with Mild Cognitive Impairment.
    Brown EE; Rashidi-Ranjbar N; Caravaggio F; Gerretsen P; Pollock BG; Mulsant BH; Rajji TK; Fischer CE; Flint A; Mah L; Herrmann N; Bowie CR; Voineskos AN; Graff-Guerrero A;
    J Neuroimaging; 2019 Nov; 29(6):721-729. PubMed ID: 31270885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter hyperintensities: relationship to amyloid and tau burden.
    Graff-Radford J; Arenaza-Urquijo EM; Knopman DS; Schwarz CG; Brown RD; Rabinstein AA; Gunter JL; Senjem ML; Przybelski SA; Lesnick T; Ward C; Mielke MM; Lowe VJ; Petersen RC; Kremers WK; Kantarci K; Jack CR; Vemuri P
    Brain; 2019 Aug; 142(8):2483-2491. PubMed ID: 31199475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extravascular fibrinogen in the white matter of Alzheimer's disease and normal aged brains: implications for fibrinogen as a biomarker for Alzheimer's disease.
    McAleese KE; Graham S; Dey M; Walker L; Erskine D; Johnson M; Johnston E; Thomas AJ; McKeith IG; DeCarli C; Attems J
    Brain Pathol; 2019 May; 29(3):414-424. PubMed ID: 30485582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between brain amyloid deposition and longitudinal changes of white matter hyperintensities.
    Cha WJ; Yi D; Ahn H; Byun MS; Chang YY; Choi JM; Kim K; Choi H; Jung G; Kang KM; Sohn CH; Lee YS; Kim YK; Lee DY
    Alzheimers Res Ther; 2024 Mar; 16(1):50. PubMed ID: 38454444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition.
    Raghavan S; Przybelski SA; Reid RI; Lesnick TG; Ramanan VK; Botha H; Matchett BJ; Murray ME; Reichard RR; Knopman DS; Graff-Radford J; Jones DT; Lowe VJ; Mielke MM; Machulda MM; Petersen RC; Kantarci K; Whitwell JL; Josephs KA; Jack CR; Vemuri P
    Acta Neuropathol Commun; 2022 Feb; 10(1):16. PubMed ID: 35123591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular burden and cognition: Mediating roles of neurodegeneration and amyloid PET.
    Ottoy J; Ozzoude M; Zukotynski K; Adamo S; Scott C; Gaudet V; Ramirez J; Swardfager W; Cogo-Moreira H; Lam B; Bhan A; Mojiri P; Kang MS; Rabin JS; Kiss A; Strother S; Bocti C; Borrie M; Chertkow H; Frayne R; Hsiung R; Laforce RJ; Noseworthy MD; Prato FS; Sahlas DJ; Smith EE; Kuo PH; Sossi V; Thiel A; Soucy JP; Tardif JC; Black SE; Goubran M;
    Alzheimers Dement; 2023 Apr; 19(4):1503-1517. PubMed ID: 36047604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of white matter hyperintensities and amyloid deposition on Alzheimer dementia.
    Gordon BA; Najmi S; Hsu P; Roe CM; Morris JC; Benzinger TL
    Neuroimage Clin; 2015; 8():246-52. PubMed ID: 26106548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrovascular disease promotes tau pathology in Alzheimer's disease.
    Laing KK; Simoes S; Baena-Caldas GP; Lao PJ; Kothiya M; Igwe KC; Chesebro AG; Houck AL; Pedraza L; Hernández AI; Li J; Zimmerman ME; Luchsinger JA; Barone FC; Moreno H; Brickman AM;
    Brain Commun; 2020; 2(2):fcaa132. PubMed ID: 33215083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological correlates of white matter hyperintensities on magnetic resonance imaging.
    Shim YS; Yang DW; Roe CM; Coats MA; Benzinger TL; Xiong C; Galvin JE; Cairns NJ; Morris JC
    Dement Geriatr Cogn Disord; 2015; 39(1-2):92-104. PubMed ID: 25401390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White Matter Hyperintensity Volume and Amyloid-PET Synergistically Impact Memory Independent of Tau-PET in Older Adults Without Dementia.
    Edwards L; Thomas KR; Weigand AJ; Edmonds EC; Clark AL; Walker KS; Brenner EK; Nation DA; Maillard P; Bondi MW; Bangen KJ;
    J Alzheimers Dis; 2023; 94(2):695-707. PubMed ID: 37302031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of amyloid and small vessel disease on white matter network disruption.
    Kim HJ; Im K; Kwon H; Lee JM; Ye BS; Kim YJ; Cho H; Choe YS; Lee KH; Kim ST; Kim JS; Lee JH; Na DL; Seo SW
    J Alzheimers Dis; 2015; 44(3):963-75. PubMed ID: 25374100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults.
    Arfanakis K; Evia AM; Leurgans SE; Cardoso LFC; Kulkarni A; Alqam N; Lopes LF; Vieira D; Bennett DA; Schneider JA
    J Alzheimers Dis; 2020; 73(1):333-345. PubMed ID: 31771057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion imaging in dementia with Lewy bodies: Associations with amyloid burden, atrophy, vascular factors and clinical features.
    Donaghy PC; Firbank M; Petrides G; Lloyd J; Barnett N; Olsen K; Thomas AJ; O'Brien JT
    Parkinsonism Relat Disord; 2020 Sep; 78():109-115. PubMed ID: 32814228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.